Why the study?
The ADAMTS family has attracted less attention in vascular research than matrix metalloproteinases, despite emerging evidence pointing to its role in vascular diseases.
Key points are not available for this paper at this time.
Design
Review
ADAMTS proteases merit mechanistic study in vascular disease; leaves open therapeutic targeting in atherosclerosis, restenosis, or aneurysms.
Members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family are involved in the degradation of extracellular matrix (ECM) proteins during development, morphogenesis, tissue repair, and remodeling. They differ from other proteases like MMPs (matrix metalloproteinases) with respect to function, binding and anchoring properties, substrate recognition, and half-life. Thus far, the ADAMTS family has attracted less attention in vascular research than MMPs (Figure 1). Recent findings, however, point towards an important role of ADAMTS family members in atherosclerosis, restenosis, and aneurysm formation.
No takes yet. Share an insight, caveat, or question.
Rienks et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: